Microbot Medical Inc. (NASDAQ:MBOT – Get Rating)’s share price passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $5.38 and traded as high as $5.88. Microbot Medical shares last traded at $5.79, with a volume of 11,585 shares trading hands.
Microbot Medical Stock Performance
The company has a 50 day moving average of $5.17 and a two-hundred day moving average of $5.38. The stock has a market cap of $41.16 million, a PE ratio of -3.15 and a beta of 3.55.
Institutional Investors Weigh In On Microbot Medical
Large investors have recently bought and sold shares of the company. Cetera Advisor Networks LLC purchased a new stake in Microbot Medical during the 1st quarter worth approximately $78,000. Blueshift Asset Management LLC purchased a new stake in Microbot Medical during the 1st quarter worth approximately $81,000. Finally, Renaissance Technologies LLC increased its stake in Microbot Medical by 52.5% during the 1st quarter. Renaissance Technologies LLC now owns 15,695 shares of the biotechnology company’s stock worth $98,000 after buying an additional 5,400 shares in the last quarter. 9.90% of the stock is currently owned by hedge funds and other institutional investors.
Microbot Medical Company Profile
Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio.
- Get a free copy of the StockNews.com research report on Microbot Medical (MBOT)
- 3 Airline Stocks Stuck in a Holding Pattern
- Roku Stock is Down but Not Out
- If You’re Hungry for Value, Take a Bite on Ruth’s Hospitality Grp
- Is Ford Rolling To A Rebound After Its Q3 Warning
- Has AMD stock stock fallen too far?
Receive News & Ratings for Microbot Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical and related companies with MarketBeat.com's FREE daily email newsletter.